Strata Oncology Archives | Page 2 of 3

News Page Strata Oncology

New Publication in JCO Precision Oncology Demonstrates the Ability of StrataNGS®

Study shows StrataNGS substantially increases patient access to tissue-based comprehensive genomic profiling.

Arboretum_JDAugust 23, 2021

Home Page News Page Strata Oncology

Strata Oncology Completes $90 Million Series C Financing

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…

Arboretum_JDJuly 28, 2021

News Page Strata Oncology

Strata Oncology Launches Strata Assistant Epic app to Integrate Precision Oncology into Clinical Practice

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…

Arboretum_JDMay 19, 2021

Home Page News Page Strata Oncology

Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma Partner

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…

Arboretum_JDMarch 2, 2021

News Page Strata Oncology

Strata Oncology Announces Personalized Recurrence Monitoring Trial

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…

Arboretum_JDJanuary 13, 2021

News Page Strata Oncology

Strata Oncology Announces Medicare Coverage of StrataNGS Comprehensive Genomic Profiling Test for Patients with Advanced Solid Tumors

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, recently announced…

Arboretum_JDOctober 28, 2020

News Page Strata Oncology

Strata Oncology Partners with Elevation Oncology to Accelerate Enrollment of CRESTONE Study for Patients with Rare NRG1 Gene Fusions

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…

Arboretum_JDJuly 21, 2020

Strata Oncology

The Future of Healthcare: With Dan Rhodes of Strata Oncology

Award-Winning Author of The Art of Healthcare Innovation interviews Dan Rhodes, PhD, Co-founder and CEO…

Arboretum_JDMarch 27, 2020

News Page Strata Oncology

Strata Oncology Announces Partnerships with Five Additional Health Systems

Strata Oncology, Inc., Strata Oncology, a precision oncology company enabling molecular indications for cancer therapeutics,…

Arboretum_JDJuly 30, 2019

Home Page News Page Strata Oncology

Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, and…

Arboretum_JDMay 2, 2019

Strata Oncology

New Publication in JCO Precision Oncology Demonstrates the Ability of StrataNGS®

Strata Oncology Completes $90 Million Series C Financing

Strata Oncology Launches Strata Assistant Epic app to Integrate Precision Oncology into Clinical Practice

Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma Partner

Strata Oncology Announces Personalized Recurrence Monitoring Trial

Strata Oncology Announces Medicare Coverage of StrataNGS Comprehensive Genomic Profiling Test for Patients with Advanced Solid Tumors

Strata Oncology Partners with Elevation Oncology to Accelerate Enrollment of CRESTONE Study for Patients with Rare NRG1 Gene Fusions

The Future of Healthcare: With Dan Rhodes of Strata Oncology

Strata Oncology Announces Partnerships with Five Additional Health Systems

Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122

News & Insights

ARCHIVES